FDA approves first drug to limit frequent waking to urinate
The Associated Press | March 03, 2017
U.S. regulators Friday approved the first drug to reduce nighttime trips to the bathroom. The treatment is a nasal spray intended for adults who wake up at least twice a night to urinate.